Matthew S. Block

Dose-Response Association of CD8⁺ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli et al. · JAMA Oncology · 2017 · 404 citations · Full text

Medicine, Immunology, Oncology +17

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

Mitesh J. Borad, Mia D. Champion, Jan B. Egan et al. · PLoS Genetics · 2014 · 342 citations · Full text

Medicine, Molecular Biology, Oncology +17

Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes

Anupam Kotwal, Candace L. Haddox, Matthew S. Block et al. · BMJ Open Diabetes Research & Care · 2019 · 223 citations · Full text

Life Sciences, Immunology, Oncology +16

Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer

Evanthia Galanis, Pamela J. Atherton, Matthew J. Maurer et al. · Cancer Research · 2014 · 178 citations · Full text

Medicine, Immunology, Oncology +16

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Hui Shen, Brooke L. Fridley, Honglin Song et al. · Nature Communications · 2013 · 169 citations · Full text

Medicine, Genetics, Oncology +17